The global Aptamers market size is projected to reach USD 343 million by 2026 at a CAGR of 17.8% from USD 151 million in 2021 during the forecast period 2021-2028.
Aptamers are single stranded oligonucleotides that have an ability to fold themselves and bind to a specific protein. This ability of binding to desired protein enables them for therapeutic use where their binding ability is exploited to inhibit protein-protein interactions. They provide an advantage over antibodies as the aptamer generation is relatively easier than the production of antibodies and is significantly cheaper as well.
With the surge in number of conducted clinical trials along with the increased awareness of advantages of aptamer over antibodies are some of the factors that have supported long-term expansion for Aptamers.
The COVID-19 pandemic which is an infectious disease led to an increased R&D in the sector for enabling the use of aptamers in the diagnostic kits for the virus detection. The example for the development and use could be the highly specialised aptamer for spike protein of COVID-19 which was developed by NeoVentures Biotechnology.
Asia Pacific is expected to be the largest market of aptamers due to the recent R&D on aptamers along with the need of the development of aptamer-based products. Amongst Asia pacific North America is expected to have the largest share of the market which is attributed to the increased financial investment into the sector.
Detailed qualitative and quantitative data & insights are provided on global, regional and country level.
|
Report Feature |
Descriptions |
|---|---|
|
Market Revenue In 2021 |
USD 151 million |
|
Growth Rate |
CAGR of 17.8% during the forecasting period, 2021-2028 |
|
Historical Data |
2018-2019 |
|
Forecast Years |
2021-2028 |
|
Base Year |
2020 |
|
Units Considered |
Revenue in USD million and CAGR from 2021 to 2028 |
|
Report Segmentation |
Product Type, Technology, Application, End Users and geography |
|
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
|
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
|
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
|
Companies Profiled |
Aptamer Group, Aptamer Sciences, Inc., Raptamer Discovery Group, SomaLogic Inc., and Aptagen, LLC |
|
Available Customization |
In addition to the market data for Aptamers, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |
Aptamers is segmented into Product Type, Technology, Application, End Users and geography.
.png)
.png)
.png)
.png)
.png)
.png)